Esperante Ventures

Venture Capital Active Netherlands
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
3
Rounds led
2
Rounds' value
$15.6M
total disclosed, rounds participated
Stages
—

Portfolio · 2

Silexion Therapeutics
Development of Innovative Treatments for Pancreatic Cancer
Led ★ 2 rounds $12.3M committed Latest: 2015-10
Atox Bio
Immunomodulators for Treatment of Infectious and Inflammatory Diseases
Led ★ 1 round $3.3M committed Latest: 2011-12

Investment activity

Portfolio by sector

Health Tech & Life Sciences2

Q&A

What is Esperante Ventures' primary investment focus by sector?
Esperante Ventures primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies in this area.
Can you name some of Esperante Ventures' portfolio companies?
Esperante Ventures' portfolio includes Atox Bio, which develops immunomodulators.
What was Esperante Ventures' most recent investment activity?
Esperante Ventures participated in an investment round in October 2015, following a round in April 2014 and December 2011.
What is the typical investment range for Esperante Ventures?
Esperante Ventures typically invests between $2.35M and $10M.
What is the funding stage of Atox Bio, a portfolio company of Esperante Ventures?
Atox Bio, a portfolio company of Esperante Ventures, is currently in the F funding stage and has raised $64.85M.
What is the funding stage of Silexion Therapeutics?
Silexion Therapeutics, a portfolio company of Esperante Ventures, is currently public and has raised $27.65M.